NAGRADE I DOBITNICI
UDRUŽENJE NUKLEARNE MEDICINE SRBIJE
 

Izvodi iz pravilnika o dodeli nagrade:
 

•       Udruženje nuklearne medicine Srbije dodeljuje godišnju nagradu Milovan Antić svojim članovima za najbolji originalni-naučni rad iz oblasti nuklearne medicine publikovan u inostranim časopisima u predhodnoj godini. Nagrada se dodeljuje u celini prvom autoru rada (član 1.)

•       Sponzor nagrade je SHERING-CIS biointernational (član 10.).

•       Realizaciju konkursa za dodelu nagrade sprovodi žiri: Dr Ljiljana Jauković (Predsednica) i  Dr Drina Janković i Dr Mila Todorović- Tirnanić (članovi)
    

Kompletan pravilnik o dedeli nagrade (PDF)

Dosadašnji pobednici:

           Ćuprija 1996

1.   MILA TIRNANIĆ-TODOROVIĆ   
     Institut za nuklearnu medicinu KC Beograd

Diagnostic approach to reflex sympathetic dystrophy after fracture: radiography or bone scintigraphy?

Eur J Nucl Med 1995; 22: 1187-93

 

     Tara 1997

2.   IVANA ŽAGAR 
     Institut za nuklearnu medicinu KC Beograd

Meta-131J-iodobenzylquanidine in the scintigraphic evaluation of neural crest tumors.

Quart J Nucl Med 1995; 39 (Suppl 1-4):13-6

     

     Sokobanja 1998

3.   DRAGANA ŠARANOVIĆ-ŠOBIĆ 
     Institut za nuklearnu medicinu KC Beograd

Assessment of early epirubicin cardiotoxicity in women with breast cancer. Anticancer Res 1997;17:3889-92

 

     Zaječar/Borsko Jezero 1999

4.   NEBOJŠA PAUNKOVIĆ  
     Centar za nuklearnu medicunu- Zaječar

The significant increase in incidence of Graves disease in Eastern Serbia during tje Civil War in tne Former Yugoslavia (1992-1995).

Thyroid 1998;8(10):37-41

 

     Kragujevac 2000

5.   DIVNA ĐOKIĆ 
     Institut za nuklearne nauke “Vinča”

Tc-99-p-aminohippuric acid as a new renal agent.

Nucl Med Commun 1999; 20: 1133-40

 

     Sremska Kamenica 2001

6.   SLOBODAN ILIĆ 
     Centar za nuklearnu medicinu KC Niš

The predictive value of 131J-hippurate clearance in prognosis of acute renal failure

Ren Fail 2000; 22(5):581-9

 

     Pirot/Zvonačja Banja 2002

7.   SLOBODAN ILIĆ   
     Centar za nuklearnu medicinu, Niš

The significance of radiopharmaceutical choice on the estimation of the absolute renal function in different stages of renal failure.

 Med Principles Pract 2001: 10:29-33.

 

     Vrnjačka Banja 2003

8.   SANJA VRANJEŠ  
     Institut za nuklearne nauke “Vinča”

Chemical and biological properties of verapamil labeled with technetium-99m: A potential myocardial imaging agents.

J Radioanal Nucle Chem 2002; 253: 81-6.

 

Beograd 2004

9.   RAJKO  SPAIC  
     Medica Nucleare, Beograd

Method to assess intake of depleted uranium.

Assessing Depleted Uranium Intake 2003; 9: 279-283

 

     Zlatibor 2005

10.  SLOBODANKA BEATOVIĆ  
     Institut za nuklearnu medicinu, KCS

Diagnosis and follow - up of primary ocular melanoma by radioimmunoscintigraphy.  

Journal of BUON 2004; 9: 299 - 302.

 

     Beograd 2006

11.  DRINA LJ JANKOVIĆ  
     Institut za nukleare nauke, Vinča, Beograd

Alteration of the organ uptake of the 99mTc-radiopharmaceuticals, 99mTc-DPD, 99mTc-DMSA, 99mTc-tin colloid and 99mTc-MAA, induced by the applied cytotoxic drugs methotrexate sodium and cyclophosphamide.   

Nuclear Medicine Communications 2005; 26(5), 415-419.

 

    Ćuprija 2008 (nagrada za 2006 godinu)

12.  VLADIMIR OBRADOVIĆ  
     Institut za nuklearnu medicinu, KCS

Radioimmunoscintigraphy of colorectal carcinomas with three different radiopharmaceuticals.

Neoplazma 2006; 53 (5): 444-449.  

 

    Niš 2008

13.  MILENA RAJIĆ  
     Centar za nuklearnu medicinu KC Niš

Radionuclide staging of renal function in type 1 diabetes mellitus.

Ren Fail 2007; 29 (6): 685-691. 

 

    VMA Beograd 2009

14.  ŠARANOVIĆ-ŠOBIĆ DRAGANA  
     Centar za nuklearnu medicinu KCS, Beograd

Assessment of non-small cell lung cancer viability and necrosis with three radiopharmaceuticals.

Hell J Nucl Med 2008; 11(1): 16-20

    
    
      Kragujevac 2010

15.   MILOVAN D. MATOVIĆ    
      Centar za nuklearnu medicinu, KC Kragujevac

Unexpected effect of furosemide on radioiodine urinary excretion in patients with differentiated thyroid carcinomas treated with 131I.
 
Thyroid 2009;19(8):843-8. (IF 3,0)

    
    
      VMA Beograd 2011

16.   JASNA MIHAILOVIĆ    
      Centar za nuklearnu medicinu, Sremska Kamenica

MRI Versus 131I Whole-Body Scintigraphy for the Detection of Lymph Node Recurrences in Differentiated Thyroid Carcinoma.
 
AJR 2010; 195: 1197-1203.

 

Dobrodošli na zvaničnu prezentaciju UNMS